THE Therapeutic Goods Administration (TGA) has decided to seek further advice in relations to amending the scheduling of psilocybin and MDMA.
The review will assess the therapeutic value, risks and benefits to public health outcomes for these substances.
A final decision is due on 22 Apr.
THE Productivity Commission has recommended prioritising prevention programs to combat chronic conditions in its interim report, Delivering quality care more efficiently, a position welcomed by public health and patient peak bodies.
CSL has released its FY2025 results, with the company recording a “strong performance”, with 5% revenue growth and a 17% increase in net profit after tax for the year.
WHOLELIFE Pharmacy & Healthfoods honoured the outstanding achievements of its people and partners at its annual WholeLife Awards Dinner, held at Crown Sydney as part of the 2025 WholeLife Conference (PD 19 Aug).
Notifications
